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Background: In the context of health-related quality of life (HrQoL) assessment in pediatric short stature, the
present study aimed to examine the levels of agreement/disagreement between parents’ and children’s reports of
generic and condition-specific HrQoL, and to identify socio-demographic, clinical and psychosocial variables
associated with the extent and direction of parent-child discrepancies.
Methods: This study was part of the retest phase of the QoLISSY project, which was a multicenter study conducted
simultaneously in France, Germany, Spain, Sweden and UK. The sample comprised 137 dyads of children/
adolescents between 8 and 18 years of age, diagnosed with growth hormone deficiency (GHD) or idiopathic short
stature (ISS), and one of their parents. The participants completed child- and parent-reported questionnaires on
generic (KIDSCREEN-10 Index) and condition-specific HrQoL (QoLISSY Core Module). Children/adolescents also
reported on social support (Oslo 3-items Social Support Scale) and parents assessed the parent-child relationships
(Parental Role subscale of the Social Adjustment Scale) and burden of short stature on parents (QoLISSY- additional
module).
Results: The parent-child agreement on reported HrQoL was strong (intraclass correlation coefficients between .59
and .80). The rates of parent-child discrepancies were 61.5 % for generic and 35.2 % for condition-specific HrQoL,
with the parents being more prone to report lower generic (42.3 %) and condition-specific HrQoL (23.7 %) than
their children. The extent of discrepancies was better explained by family and social relationships than by clinical
and socio-demographic variables: poorer parent-child relationships and better children’s social support were
associated with larger discrepancies in generic HrQoL, while more parental burden was associated with larger
discrepancies in condition-specific HrQoL reports. Regarding the direction of discrepancies, higher parental burden
was significantly associated with parents’ underrating, and better children’s social support was significantly
associated with parents’ overrating of condition-specific HrQoL.
Conclusions: Routine assessment of pediatric HrQoL in healthcare and research contexts should include child- and
parent-reported data as complementary sources of information, and also consider the family and social context.
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Short stature is a chronic health condition statistically
defined as a body height of two or more standard devia-
tions (SD) below the mean for age and gender specific
norms [1]. The diagnosis of growth hormone deficiency
(GHD) in children requires a comprehensive clinical and
auxological assessment, combined with biochemical tests
and radiological evaluation [2]. However, GHD repre-
sents only 5 % of cases [3] and alternative causes of
short stature and low growth velocity for age and puber-
tal stage need to be also considered and excluded. One
of the normal variants is idiopathic short stature (ISS), a
group of short children with sufficient growth hormone
(GH) secretion, normal birth size and no evidence of
systemic disease, psychiatric disorders or malnutrition
[4]. The psychosocial consequences of short stature are
well documented in the literature, but findings across
studies are frequently contradictory [5]. While some
studies have described significant health-related quality
of life (HrQoL) impairment and more psychological
problems among children and adolescents with GHD or
ISS [6, 7], other studies have failed to detect differences
from population norms [8]. The inconsistent results
across studies can be attributed to methodological is-
sues, namely the sources of information and the mea-
sures used to assess health outcomes. Parents of
children with short stature tend to rate their children as
having lower social functioning, poorer self-esteem, and
more behavioral and cognitive problems than children
with average height, while this view is rarely shared by
young patients [9, 10]. This limited parent-child agree-
ment calls for capturing both patients’ and parents’ re-
ports in order to better understand the impact of short
stature on children’s wellbeing and functioning [11].
Over the past years, a number of cross-culturally vali-
dated instruments have been developed to assess HrQoL
in children and adolescents because of the growing
interest on the perception and evaluation of an individ-
ual’s own life from a subjective perspective. The value of
obtaining children’s self-reports about their health, func-
tioning, abilities, and emotions is increasingly recognized
within both medical care and child health research [12]
and, thus, self-assessment of HrQoL is generally prefera-
ble to observer assessments. However, this is only pos-
sible for children and adolescents who are capable of
providing the necessary information as a result of their
age, their cognitive development, language skills and
their health state [13]. Therefore, the majority of
pediatric HrQoL instruments have been developed for
children above 8 years of age and observer reports (usu-
ally a parent) have been used to gain information about
younger children [14]. Several generic and disease-
specific HrQoL measures that include parallel child- and
parent-report versions are currently available, such asthe generic KIDSCREEN [15], the chronic-generic DIS-
ABKIDS [16] and the short stature specific Quality of
Life in Short Stature Youth (QoLISSY) [17].
There is considerable debate about the value of observa-
tional assessments (by clinicians or parents) and it has been
argued that children and adolescents may operate within
different reference systems and thus differ from adults in
their understanding of HrQoL [13]. While parents can eas-
ily identify behavioral problems, this may not be the case
with emotional problems such as sadness or tension [18].
Parents often lack first-hand information, especially regard-
ing their child’s social functioning. Verhey and colleagues
[19] also stressed that private feelings experienced by chil-
dren and youth with a chronic disease and their desire to
keep these experiences as a secret means that parents may
be unaware of the nonvisible experiences and non-
expressed feelings of their children. Still, parent-reports
provide important complementary information about chil-
dren’s HrQoL [20], especially since parents have more de-
veloped cognitive capabilities and life experiences than
their children, enabling them to think about the future con-
cerns of their child and how they might adapt to life with a
chronic health condition later in life. Specifically in
pediatric short stature, parental concerns about their child’s
physical health and psychosocial well-being have been re-
ported as important factors that contribute to the increase
of both referrals by primary care providers to specialists
and prescriptions of GH by endocrinologists, regardless of
objective measures of the child’s growth [21–23].
The availability of measures with parallel child and
parent versions has raised questions about the level of
agreement between children’s own views and those of
their parents [12]. It has been argued that discrepancies
between child- and parent-reports could validly reflect
each respondent’s perspective and they are not merely
due to inaccuracy or bias [24] and that a number of
studies and reviews in recent years have examined
parent-child (dis)agreement [13, 25]. However, the litera-
ture is relatively incosistent, with reports of poor/moder-
ate to high parent-child agreement. In their review about
child and parent quality of life (QoL) ratings, Eiser and
Morse [13] concluded that agreement is dependent on
the domain being measured, with higher levels of agree-
ment for physical aspects of health compared to emo-
tional or social dimensions. There is also evidence of
higher agreement between parents and their chronically
ill children compared to parents and their healthy chil-
dren [26]. While parents, in general, tend to overesti-
mate their healthy child’s HrQoL [12, 26–28], parents of
chronically ill children tend to rate their child’s HrQoL
lower than the children do themselves [29, 30].
Agreement between child- and parent-ratings may also
vary by the age of the child. Although some studies have
described greater agreement between parents and
Quitmann et al. Health and Quality of Life Outcomes  (2016) 14:150 Page 3 of 12younger children, suggesting that increasing independ-
ence in adolescence may limit the sharing of experiences
with parents [31, 32], other studies have reported that
younger age predicts greater differences between parents
and children [33, 34]. An additional factor for consider-
ation here is the impact of parents’ own functioning and
well-being. Eiser et al. [35] found that mothers who
rated their own well-being as poor also rated their child’s
QoL as poor, suggesting that parents project their own
feelings in the judgments about the child’s functioning.
These findings were supported by a study from Davis
et al. [36], who highlighted the importance of assessing
maternal mental health when measuring parent-reported
HrQoL. In addition, Goldbeck and Melches [37] re-
ported a significant interaction effect of parental QoL
and patients’ self-reported QoL in predicting parental re-
ports of their children’s QoL. Another study, which ex-
amined the factors influencing agreement between child
self-reports and parent observer-reports [38] also
showed that parent-child agreement in healthy popula-
tions can be affected by the parents’ own QoL, the do-
mains being investigated and the children’s age.
Verhey et al. [19] described agreement between parent
observer-reports and child self-reports as a function of the
measure of concreteness, visibility, and externality of the
variable being measured, which applies when QoL is con-
ceptualized as a functional and objective phenomenon
that incorporates factors such as functional impairment,
emotional health, social activity, and cognitive functioning.
When incorporating internal factors, such as self-
perception in relationships and experience of social sup-
port into the measurement of QoL, agreement is less
likely because parents’ psychosocial stressors and burden
of their child’s disease could also negatively affect the
parent-child communication and, thus, the extent to
which a parent is able to comment on the child’s QoL.
Another possible reason for the disagreement is that chil-
dren with chronic diseases may be more prone to focus
on and recall the positive experiences because they are en-
gaged in a quest for normality, whereas parents tend to re-
port negative perceptions in the life of their child in
addition to positive ones, perhaps reflecting their worries
about the future [39].
Due to these inconsistent findings and the fact that
Brütt et al. [40] identified just seven generic and only
five condition-specific instruments to examine the QoL
of short statured children and adolescents, the aim of
this study was to extend knowledge of the factors influ-
encing child-parent (dis)agreement in short stature. Spe-
cific objectives were to examine the levels of
(dis)agreement between parents’ and children’s reports
of generic and condition-specific HrQoL, and to identify
socio-demographic, clinical and psychosocial variables
associated with the extent and direction of parent-childdiscrepancies, in a sample of 137 dyads of parents and
their children diagnosed with GHD or ISS.
Methods
Participants and procedures
This study was part of the European Quality of Life in
Short Stature Youth (QoLISSY) project, which was a
multicenter study conducted simultaneously in five
European countries (France, Germany, Spain, Sweden
and UK) with the objective of developing a condition-
specific HrQoL instrument for short statured children
and adolescents between 8 and 18 years of age, as well
as for parents of children aged 4–18 years-old [17]. Ac-
cording to standardized guidelines, the development of
the QoLISSY instrument was carried out in three stages:
(1) focus-groups with item generation, (2) pilot-test with
cognitive debriefing, and (3) field test with retest [41].
The QoLISSY project was approved by the Ethics Com-
mittees at the pediatric endocrine centers where patients
were recruited, as required by national regulation of the
participating countries (namely, die Ethikkommission
der Ärztekammer Hamburg, Deutschland; the METC;
Onderwijscoordinatie & projecten in 1201 DA Hilver-
sum; the Regionala etikprövningsnämnden I Göteburg,
the Universitair Ziekenhuis Brussel, Commissie Med-
ische Ethiek, the Comité d’ethique de Toulouse, France;
the research ethics committee, NHS Lothian, Edinburgh,
and the CEIC Hospital Clínic de Barcelona). Data collec-
tion and analysis were performed following data protec-
tion requirements of the European Parliament (Directive
95/46/EC of the European Parliament and of the Council
of 24 October 1995 on the protection of individuals with
regard to the processing and free movement of personal
data).
In each of the collaborating countries, eligible patients
were identified by the pediatric endocrinologists based
on medical records. Detailed information about the
study aims and procedures was provided in each respect-
ive language when the families attended to the endocrine
centers for regular appointments. Informed consent was
obtained from parents, together with informal assent
from children/adolescents, as well as permission to ex-
tract medical data from the clinical records through
their physicians. For the families who agreed to partici-
pate, the questionnaires that were to be independently
completed by patients and parents were delivered by
hand or sent by mail, together with a pre-stamped enve-
lope for returning the completed questionnaires to the
respective center. With the aim to receive data from
about 50 % of the sample to examine test-retest reliabil-
ity of assessment instruments, subjects who agreed to
participate in the retest phase received a second mail
about 2 weeks later. Additional measures were included
in the retest to identify potential psychosocial
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data were entered into a project specific SPSS database
in each center, which included the computation of the
height deviation at the time of assessment with reference
to the national norms for age and gender, and was sub-
sequently sent to the German coordinating center.
The current analyses use data from the participants in
both field test and retest phases of the QoLISSY project.
To be included in the sample, children and adolescents
had to meet the following criteria: age between 8 and
18 years-old; clinical diagnosis of GHD or ISS; height
below -2 SD from the norms for their age, gender and
nationality, at the time of diagnosis; absence of defined
comorbid chronic health conditions; and cognitive abil-
ity to understand and complete the questionnaires. One
of the parents of the child/adolescent was included, as
were parents of children aged 4–7 years (not included in
the current analyses). In the field test phase, a total of
544 questionnaires were sent out to families and 337
(61.95 %) were returned to the growth clinics. The re-
sponse rate across countries ranged from 48 to 92 %.
Twelve questionnaires were excluded due to missing
values in a ratio greater than 25 % of the values, totaling
325 participants in the field test. Of these, 165 partici-
pants also returned the retest questionnaires, represent-
ing about 50 % of the baseline sample, as planned. AfterTable 1 Socio-demographic and clinical characteristic of the sample
Sociodemographic characteristics
Age (in years), M (SD)
Age group, n (%) Children 8–12 years
Adolescents 13–18 years
Sex, n (%) Male
Female
Missing






Diagnosis, n (%) GHD
ISS
Treatment status, n (%) GH treatment
Untreated
Missing
Height deviation, n (%) Above –2 SD (achieved normal he
Below –2 SD (current short stature
Missingsubtracting the 28 patients aged between 4 and 7 years
(because only parent-reports were included for this age
group), the sample for the present study included 137
dyads of children/adolescents between 8 and 18 years of
age, diagnosed with GHD or ISS, and one of their par-
ents. The socio-demographic and clinical characteristics
of the sample are presented in Table 1.
Variables and measures
Health-related quality of life
The children’s and adolescents’ HrQoL were measured
at the generic and condition-specific levels by the
KIDSCREEN-10 Index and the core module of the
QoLISSY questionnaire, respectively. The KIDSCREEN-
10 Index [42] is a generic one-dimensional questionnaire
which contains 10 items measuring physical well-being
(e.g., “Have you felt fit and well?”), psychological well-
being (e.g., “Have you felt sad?”), parent relations and
autonomy (e.g., “Have your parent(s) treated you
fairly?”), social support and peers (e.g., “Have you had
fun with your friends?”), and school environment (e.g.,
“Have you got on well at school?”), with parallel forms
to be answered by 8–18 year-old children/adolescents
and by their parents/caregivers. The QoLISSY question-
naire is a condition-specific instrument targeting
patient-reported HrQoL of 8–18 year-old children/Children (n = 137) Parents (n = 137)
13.30 (2.74) 43.88 (5.15)
59 (43.1 %)
78 (56.9 %)
68 (49.6 %) 17 (12.4 %)
56 (40.9 %) 104 (75.9 %)











ight) 24 (17.5 %)
) 71 (51.8 %)
42 (30.7 %)
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reported HrQoL of 4–18 year-old patients [17]. Its core
module consists of 22 items, assessing three HrQoL do-
mains: Physical (six items measuring the physical limita-
tions in everyday life due to short stature; e.g., “My
height prevents me from doing things that other chil-
dren my age do.”), Social (eight items referring to the
way short stature interferes with the child’s social life;
e.g., “Because of my height I get laughed at or teased.”),
and Emotional (eight items assessing the child’s feelings
and emotions with regards to his/her short stature; e.g.,
“Because of my height I feel different from others my
age.”). Both questionnaires were answered using a five-
point Likert scale ranging from 1 (never/not at all) to 5
(always/extremely). Standardized scores ranging from 0
to 100 were calculated for the KIDSCREEN index and
for the QoLISSY Physical, Social and Emotional domains
and total score, with higher scores indicating better
HrQoL. Both child- and parent-report forms demon-
strated good reliability in the current sample (see
Table 2).
Family and social relationships
Parent-child relationships were assessed by both family
members-the child and the parent-with the Parental
Role scale of the Social Adjustment Scale-Self Report
(SAS-SR) [43]. The SAS-SR is a 42-item questionnaire,
measuring instrumental and expressive role performanceTable 2 Descriptive statistics, intraclass correlation coefficients, ANC
discrepancies
Parent-report Child-report ANCOVA for
repeated meas
Baseline M (SD) α M (SD) α ICC a F p
KIDSCREEN-10 73.15 (13.10) .83 77.02 (14.02) .84 .65 0.31 .58
QoLISSY-22 71.09 (22.63) .95 75.34 (20.66) .93 .75 2.28 .14
Physical QoL 73.67 (20.99) .83 73.76 (20.29) .77 .68 0.03 .87
Social QoL 71.52 (27.14) .93 76.31 (22.65) .87 .73 5.32 .02
Emotional QoL 68.72 (23.54) .86 75.57 (24.27) .85 .66 1.16 .29
Retest M (SD) α M (SD) α ICC a F p
KIDSCREEN-10 76.43 (12.69) .82 78.99 (15.74) .88 .59 2.58 .11
QoLISSY-22 70.86 (22.39) .95 73.81 (22.77) .95 .80 2.52 .12
Physical QoL 72.42 (21.49) .83 73.04 (21.58) .81 .77 0.04 .85
Social QoL 70.93 (25.49) .91 73.93 (25.23) .89 .77 4.49 .04
Emotional QoL 69.61 (24.19) .87 74.28 (24.83) .87 .72 2.35 .13
a Intraclass correlation coefficients reference values: ICC < .40 = poor agreement, ICC
agreement, ICC > .81 = excellent agreement (Landis & Koch, 1977). All ICCs were sta
b Univariate analyses of covariance for repeated measures, entering the informant (
clinical variables (children’s sex and age group, diagnosis, treatment status and heig
c Absolute discrepancy = Σ (|parent score - child score|)/number of items for each d
d Directional discrepancy = Σ (parent score - child score)/number of items for each d
e Univariate analyses of covariance for repeated measures, entering the time of ass
demographic and clinical variables (children’s sex and age group, diagnosis, treatmover the past 2 weeks in six major areas of social func-
tioning: work (either as a paid worker, homemaker, or
student); social and leisure activities; relationships with
extended family; role as a marital partner; parental role;
and role within the family unit, including perceptions
about economic functioning. The questions within the
parental role area cover four categories: lack of involve-
ment (e.g., “Have you been interested in what your chil-
dren are doing-school, play or hobbies during the last
2 weeks?”), impaired communication (e.g., “Have you
been able to talk and listen to your children during the
last 2 weeks?”), friction (e.g., “How have you been get-
ting along with the children during the last 2 weeks?”)
and lack of affection (e.g., “How have you felt toward
your children these last 2 weeks?”). Each item was rated
on a five-point scale and a total score for the parental
role area was calculated by summing up the scores of all
the items within that area, with higher scores indicating
more adjusted parent-child relationships. In the current
sample, the Cronbach’s alpha value was .83 for child-
reports and .77 for parent-reports, attesting the adequate
reliability of the measure.
Social support was assessed by the children/adoles-
cents using the Oslo 3-items Social Support Scale (OSS-
3) [44], which is a brief measure composed of three
items assessing the number of close confidants (“How
many people are so close to you that you can count on
them if you have serious problems?”), sense of concernOVA for repeated measures, and absolute and directional
ures b
Discrepancy ANCOVA for repeated measures e




M (SD) M (SD)
9.15 (6.77) −4.07 (10.66)
11.49 (11.46) −1.02 (16.23)
12.73 (12.38) −2.91 (17.55)
13.97 (13.06) −5.58 (18.33)
10.86 (10.11) −3.22 (14.51)
M (SD) M (SD) F p F p
9.77 (7.87) −3.77 (11.99) 0.28 .60 0.70 .41
10.44 (10.29) −0.84 (14.66) 2.16 .15 0.11 .74
11.54 (11.97) −2.79 (16.42) 0.39 .54 0.01 .91
12.63 (12.03) −4.55 (16.87) 0.45 .51 0.03 .86
9.63 (10.12) −2.90 (13.69) 0.78 .38 0.01 .93
between .41 and .60 =moderate agreement, ICC between .61 and .80 = good
tistically significant at the .01 level
parent vs. child) as the within-subject factor and the socio-demographic and
ht deviation) as covariates, at baseline and retest
imension
imension
essment (baseline vs. retest) as the within-subject factor and the socio-
ent status and height deviation) as covariates
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people show in what you are doing?”), and relation-
ship to neighbors (“How easy can you get practical
help from neighbors if you should need it?”). Al-
though the response categories are independent for
each of the three questions, a total score can be ob-
tained for the OSS-3 by adding up the raw scores
(range between 3 and 14 points), with higher scores
indicating stronger perceived social support. The low
Cronbach’s alpha coefficients found in the original
study (α = .60) and in the current sample (α = .44)
may reflect the multidimensionality of the social sup-
port construct, including its structural (quantitative
dimension related to the amount of people in the in-
dividual’s social network and the amount of intercon-
nections between its members) and functional
dimensions (qualitative dimension referring to the
emotional, instrumental and informational resources
provided by social interactions) [45]. Despite the low
reliability of the social support composite index, the
feasibility of the OSS-3 and its predictive validity re-
garding psychosocial distress has been confirmed in
several studies [46, 47].
Finally, the burden of the child’s short stature on
the parents was assessed with the Effects on Parents
scale of the QoLISSY questionnaire [17]. This scale is
embedded in the parent-report version and was devel-
oped as a complementary scale for assessing potential
determinants of pediatric HrQoL (along with Coping,
Height-related Beliefs, Treatment Experiences and
Concerns about the child’s Future scales, which were
not included in the present study). The Effects on
Parents scale consists of 11 items (e.g., “My child’s
growth problems make me feel anxious.”) scored on a
5-point Likert scale ranging from 1 (never/not at all)
to 5 (always/extremely) and providing a 0–100 stan-
dardized score, with higher scores indicating less
negative effects of the child’s condition on the par-
ents. In the current sample, the scale presented very
good reliability, with a Cronbach’s alpha value of .92.
Socio-demographic and clinical data
The socio-demographic data included patients’ and
parents’ sex, date of birth and nationality. Physician-
reported clinical data included diagnosis (GHD or
ISS), treatment status and height at time of diagnosis
and at time of assessment. The treated group con-
sisted of patients receiving rhGH treatment at the
time of assessment and before; the untreated group
had never been treated. Although a height deviation
greater than -2SD at time of diagnosis was required
for patient inclusion, some had an achieved height
above -2SD at the time of assessment due to treat-
ment. Thus, the current height deviation wascategorized into two groups: achieved normal height
(height deviation > -2 SD) and current short stature
(height deviation ≤ -2 SD).
Data analyses
Statistical analyses were performed with SPSS 20.0 (SPSS
Inc., Chicago, IL, USA). Except for clinical and socio-
demographic variables, missing data were handled by in-
dividual mean score allocation, if they were random and
less than 25 % of the values. Descriptive statistics were
calculated for socio-demographic and clinical variables.
The child-parent (dis)agreement on baseline and retest
reports of HrQoL were examined at the individual and
the group levels [48], by using, respectively, intraclass
correlation coefficients [ICC] (two-way mixed model, ab-
solute agreement, 95 % confidence interval [CI]) and
analyses of covariance for repeated measures. We per-
formed univariate analyses of covariance for the total
scores on generic KIDSCREEN and condition-specific
QoLISSY measures, and multivariate analyses of covari-
ance for the three core dimensions of condition-specific
HrQoL (i.e., physical, social and emotional), entering the
informant (parent vs. child) as the within-subject factor
and the socio-demographic and clinical variables (chil-
dren’s sex and age group, diagnosis, treatment status and
height deviation) as covariates.
Absolute discrepancies (the mean of the absolute
differences between the reports from the parent and
the child) and directional discrepancies (the mean of
the parent-child differences) were computed as
dyadic indexes of the extent and direction of dis-
agreement, respectively [49]. Directional discrepan-
cies were categorized into three groups (“parent-
report < child-report”, “agreement” and “parent-re-
port > child-report”) based on the threshold for clin-
ically important differences in quality of life [50].
Thus, agreement was defined as an absolute differ-
ence between the parent’s and the child’s scores that
were lower than or equal to half of the standard de-
viation (SD) of the score with the greatest variability.
Differences in absolute and directional parent-child
discrepancies from the baseline to the retest were
examined with univariate analyses of covariance for
the total scores on KIDSCREEN and QoLISSY mea-
sures, and multivariate analyses of covariance for the
three core dimensions of condition-specific HrQoL,
entering the time of assessment (baseline vs. retest)
as the within-subject factor and the socio-
demographic and clinical variables as covariates.
In order to identify the clinical, socio-demographic
and psychosocial variables associated with the extent of
parent-child discrepancies (absolute discrepancies), hier-
archical multiple regression analyses were performed,
entering the clinical and sociodemographic variables
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and height deviation) in the first block and the psycho-
social variables (i.e., parent-child relationships as
perceived by both family members, children’s social
support and burden of the child’s short stature on
the parents) in the second block of the regression equa-
tion. Multinomial logistic regressions, using “agreement”
as the reference category [51], were performed to identify
which variables were associated with the direction of the
parent-child discrepancies (directional discrepancies). The
clinical and sociodemographic variables were entered in
the equation as categorical factors and the psychosocial
variables as covariates. The goodness-of-fit of the overall
model was evaluated using the likelihood ratio tests, as
well as the Cox and Snell’s R2 and Nagelkerke’s adjusted
R2 as indicators of effects sizes, considering R2 > .10 as
small effect, R2 > .30 as medium effect, and R2 > .50 as
large effect [52]; and the statistical significance of individ-
ual predictors was evaluated by calculating the Wald stat-
istic and the odds ratio (OR) with a 95 % CI.Results
Parent-child (dis)agreement
At the individual level, there were strong intraclass
correlations between children’s and parents’ reports
of generic and condition-specific HrQoL, at both
baseline and retest (Table 2). At the group level, the
results indicated that the parents’ and children’s re-
ports of generic and condition-specific HrQoL (total
scores) were not significantly different, after control-
ling for socio-demographic and clinical variables. In
addition, the multivariate effect of the informant on
three core domains of condition-specific HrQoL did
not reached statistical significance, Wilks’ Lambda
= .92, F(3, 84) = 2.46, p = .07 at baseline, and Wilks’
Lambda = .93, F(3, 83) = 2.16, p = .10 at retest, even if
the univariate analyses (Table 2) suggested that par-
ents’ and children’s reports of social HrQoL were
significantly different, with children rating their so-
cial HrQoL as higher than did the parents.
As depicted in Fig. 1, the examination of the parent-child
discrepancies indicated higher rates of agreement for the
condition-specific measure (61.2 % at baseline and 64.9 %
at retest) than for the generic HrQoL assessment (41.5 % at
baseline and 38.5 % at retest). In cases where disagreement
occurred, parents were more likely to rate both generic and
condition-specific HrQoL lower than did the children
themselves. The multivariate analyses of covariance for re-
peated measures indicated no significant differences in the
extent, Wilks’ Lambda = .96, F(3, 82) = 1.05, p = .37, or direc-
tion of parent-child discrepancies, Wilks’ Lambda = 1.00,
F(3, 82) = 0.06, p = .98, from the baseline to the retest. The
results for univariate analyses are presented in Table 2.Regression analyses explaining the extent of
disagreement
The results from the hierarchical regression analyses
conducted to identify the variables associated with the
extent of the parent-child disagreement (Table 3)
showed that the clinical and sociodemographic vari-
ables did not contribute significantly to explain the
variance of absolute discrepancies in generic (ΔR2
= .06; F(5, 63) = 0.74, p = .59) and condition-specific
(ΔR2 = .13; F(5, 64) = 1.88, p = .11) HrQoL reports.
However, controlling for children’s sex, age group,
diagnosis, treatment status and current height devi-
ation, a significant proportion of the variance of
parent-child absolute discrepancies was explained by
the psychosocial variables (ΔR2 = .20; F(4, 59) = 3.89, p
< .01 for generic HrQoL reports; ΔR2 = .17; F(4, 60) =
3.54, p = .01 for condition-specific HrQoL reports).
Specifically, poorer parent-child relationships as per-
ceived by the parents (β = -.39; t = -2.71, p < .01) and
better children’s perceptions of social support (β = .30;
t = 2.30, p = .03) were associated with larger discrepan-
cies in generic HrQoL reports, while greater parental
burden was associated with larger discrepancies in
condition-specific HrQoL (β = -.42; t = -3.28, p < .01).
Regression analyses explaining the direction of
disagreement
The results from multinomial logistic regression ana-
lyses explaining the direction of parent-child disagree-
ment (i.e., “child-report > parent-report” and “child-
report < parent-report” versus “agreement”) are pre-
sented in Table 4. Although the overall model testing
the clinical, sociodemographic and psychosocial pre-
dictors of directional discrepancies in generic HrQoL
reports as assessed by the KIDSCREEN questionnaire
(-2 Log-Likelihood = 114.21) was significantly better
than the baseline model in which only the constant
was included (-2 Log-Likelihood = 147.04; χ2(18) = 32.83,
p = .02), no contribution of the individual predictors
reached statistical significance. On the contrary, more
burden of the child’s short stature on the parents was
significantly associated with larger discrepancies in
the direction of parents reporting worse condition-
specific HrQoL than the children (Wald χ2(1) = 9.69, p
< .01; OR = 0.96, 95 % CI: 0.93–0.98) and better chil-
dren’s perceptions of social support were significantly
associated with an increased likelihood of discrepan-
cies in the direction of parents’ overrating pediatric
HrQoL (Wald χ2(1) = 6.70, p = .01; OR = 2.43, 95 % CI:
1.24–4.75). The sociodemographic and clinical vari-
ables were not significantly associated with any direc-
tion of child-parent discrepancies in the QoLISSY
questionnaire. The overall model testing the predic-
tors of directional discrepancies in condition-specific
Fig. 1 Distribution of parent-child directional discrepancies on reports of generic and condition-specific HrQoL total scores
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cantly better than the baseline model in which only
the constant was included (-2 Log-Likelihood =
118.80; χ2(18) = 32.81, p = .02), with a medium effect
size (R2Cox & Snell = .37; R
2
Nagelkerke = .46).Table 3 Hierarchical regression model explaining the extent of pare
Absolute parent-chil
Generic HrQoL
R2 = .25; F(9, 59) = 2.22
First step: ΔR2 = .06; F(5, 63) = 0.7
Sociodemographic and clinical variables B (SE)
Children’s sex a 0.48 (1.83)
Children’s age group b −2.12 (2.07)
Diagnosis c −4.10 (2.20)
GH treatment d 2.67 (3.00)
Current height deviation e −0.04 (2.04)
Second step: ΔR2 = .20; F(4, 59) = 3.8
Psychosocial variables B (SE)
Children’s sex a −0.30 (1.76)
Children’s age group b −1.08 (2.00)
Diagnosis c −6.04 (2.24)
GH treatment d 2.59 (2.77)
Current height deviation e −0.70 (2.02)
parent-child relationships (child’s view) 0.27 (0.34)
parent-child relationships (parent’s view) −1.19 (0.44)
Children’s social support 1.16 (0.50)
Parental burden −0.05 (0.33)
** p < .01, two-tailed. * p < .05, two-tailed
a Reference group: 0 = female; b Reference group: 0 = children 8–12 years-old; c Refe
ing/have received GH treatment; e Reference group: 0 = height deviation above -2 SDiscussion
To our knowledge, this is the first study examining the
child-parent (dis)agreement in a sample of short statured
children. The results of this study showed that agree-




R2 = .29; F(9, 60) = 2.78
**
4 ΔR2 = .13; F(5, 64) = 1.88
t B (SE) t
0.26 −0.99 (2.37) −0.42
−1.03 −2.29 (2.69) −0.85
−1.87 1.74 (2.87) 0.61
0.89 6.15 (3.78) 1.63
−0.02 −3.37 (2.66) −1.27
9** ΔR2 = .17; F(4, 60) = 3.54
*
t B (SE) t
−0.17 −2.09 (2.30) −0.91
−0.54 −0.48 (2.61) −0.18
−2.70** −2.49 (2.95) −0.85
0.94 6.75 (3.52) 1.92
−0.35 −1.89 (2.64) −0.72
0.79 0.01 (0.44) 0.01
−2.71** −0.03 (0.58) −0.05
2.30* 1.12 (0.65) 1.71
−1.48 −0.14 (0.04) −3.28**
rence group: 0 = growth hormone deficiency; d Reference group: 0 = be receiv-
D (achieved normal height)
Table 4 Multinomial logistic regression model explaining the direction of parent-child discrepancies
Directional parent-child discrepancies
Generic HrQoL
R2 = .38(Cox & Snell); .43 (Nagelkerke)
Model χ2(18) = 32.83*
Condition-specific HrQoL
R2 = .37(Cox & Snell); .46 (Nagelkerke) Model χ2(18) = 32.81*
Child-report > Parent-report vs. Agreement B (SE) OR (95 % CI) B (SE) OR (95 % CI)
Children’s sex a 0.60 (0.70) 1.83 (0.47/7.16) 1.22 (0.78) 3.39 (0.76/15.20)
Children’s age group b 1.38 (0.76) 3.97 (0.90/17.51) 0.46 (0.83) 1.58 (0.31/7.96)
Diagnosis c 1.40 (0.92) 4.05 (0.67/24.64) 0.66 (0.95) 1.94 (0.30/12.35)
GH treatment d −1.11 (1.08) 0.33 (0.04/2.75) 0.43 (1.02) 1.54 (0.21/11.28)
Current height deviation e 0.58 (0.73) 1.78 (0.42/7.49) 0.51 (0.76) 1.67 (0.37/7.46)
parent-child relationships (child’s view) 0.11 (0.13) 1.11 (0.86/1.44) 0.16 (0.14) 1.17 (0.89/1.53)
parent-child relationships (parent’s view) −0.29 (0.18) 0.75 (0.53/1.07) −0.23 (0.17) 0.79 (0.57/1.10)
Children’s social support 0.37 (0.21) 1.44 (0.96/2.15) 0.24 (0.22) 1.27 (0.82/1.97)
Parental burden −0.01 (0.01) 0.99 (0.96/1.01) −0.04 (0.01) 0.96 (0.93/0.98)**
Child-report < Parent-report vs. Agreement B (SE) OR (95 % CI) B (SE) OR (95 % CI)
Children’s sex a −1.44 (0.85) 0.24 (0.04/1.26) −0.68 (1.38) 0.51 (0.03/7.54)
Children’s age group b −0.94 (1.02) 0.39 (0.05/2.89) −1.00 (1.34) 0.37 (0.03/5.09)
Diagnosis c 1.37 (1.08) 3.95 (0.47/32.87) 1.10 (1.63) 3.00 (0.12/73.57)
GH treatment d −1.65 (1.37) 0.19 (0.01/2.83) −1.70 (1.90) 0.18 (0.01/7.57)
Current height deviation e −1.30 (1.07) 0.27 (0.03/2.24) 0.71 (1.40) 2.04 (0.12/31.67)
parent-child relationships (child’s view) −0.21 (0.16) 0.81 (0.60/1.11) 0.08 (0.21) 1.08 (0.71/1.64)
parent-child relationships (parent’s view) 0.12 (0.23) 1.13 (0.72/1.76) 0.04 (0.33) 1.04 (0.55/1.97)
Children’s social support 0.13 (0.24) 1.14 (0.72/1.81) 0.89 (0.34) 2.43 (1.24/4.75)**
Parental burden −0.01 (0.02) 0.99 (0.96/1.02) 0.01 (0.03) 1.00 (0.96/1.06)
* p < .05, two-tailed. ** p < .01, two-tailed
a Reference group: 0 = female; b Reference group: 0 = children 8–12 years-old; c Reference group: 0 = growth hormone deficiency; d Reference group: 0 = be receiv-
ing/have received GH treatment; e Reference group: 0 = height deviation above -2 SD (achieved normal height)
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direction of discrepancies were better explained by
family and social relationships than by socio-
demographic and clinical variables. Inconsistent with
previous findings from the literature [13, 25], which
advocate moderate levels of agreement in pediatric
HrQoL assessment, we have found strong intraclass
correlations between children’s and parents’ reports of
generic and condition-specific HrQoL, with higher
rates of agreement for the condition-specific QoLISSY
questionnaire than for the generic KIDSCREEN ques-
tionnaire. Upton et al. [53] stated that the levels of
agreement would depend on the relevance of different
domains for a specific clinical group because parents
would be most alert to the frailest domains of their
children’s HrQoL. The greater level of agreement
found for the short stature-specific measure may be
explained by the relevance of the questions for this
particular group of children and adolescents, diag-
nosed with GHD or ISS, and by the higher likelihood
of parents to be more alert to stature-related issues
than general aspects of HrQoL. When disagreementoccurred, it was likely to be in the direction of par-
ents reporting worse HrQoL than their children. The
same pattern was found in other studies with chil-
dren/adolescents with chronic health conditions [25,
54], but opposite to that observed in healthy popula-
tions. These results may reflect, on the one hand, the
children’s tendency to emphasize the positive aspects
of adaptation [55] and, on the other hand, the par-
ents’ reliability in identifying the most strongly af-
fected areas of their children’s functioning [56].
Surprisingly, the clinical and sociodemographic
variables did not contribute significantly to explain
the extent or direction of parent-child discrepancies.
Previous research has also reported inconsistent
findings regarding the children’s characteristics as
factors influencing agreement rates, for example, Pet-
sios and colleagues [57] found higher levels of agree-
ment for older children supporting the hypothesis
that the levels of agreement would depend on the
cognitive and communication skills, while other
studies [31, 32] described greater agreement between
parents and younger children, suggesting that the
Quitmann et al. Health and Quality of Life Outcomes  (2016) 14:150 Page 10 of 12development of independence during adolescence
may limit the sharing of experiences with parents.
Conversely, the extent and direction of parent-child dis-
crepancies on HrQoL reports were mainly explained by
family- and social-related factors. Poorer parent-child rela-
tionships as perceived by the parents were associated with
larger absolute discrepancies in generic HrQoL. This is im-
portant since the family context characterized by the par-
ents’ ability to talk and listen to their child, by affection
toward the child and actual interest in what the child is
doing may allow children to openly express his/her worries
and feelings. More than development-related communica-
tion skills, these parental attitudes may lead to an improved
parental understanding of their child’s psychosocial func-
tioning and decreasing discrepancies in HrQoL reports. It
is also important to note that only the parents’ (and not the
children’s) perceptions of parent-child relationships were
significant predictors of absolute discrepancies; this may be
explained by the parents’ greater awareness of their active
efforts to listen and be attentive to their children’s needs.
Children’s perceptions of better social support were
associated with larger absolute discrepancies in gen-
eric HrQoL and with larger discrepancies in the dir-
ection of parents reporting better condition-specific
HrQoL than the children. These results suggest that
a wide social network, in addition to parental sup-
port, can reduce parent-child communication and in-
crease the discrepancy in HrQoL reports. This
“negative” effect of social support in parent-child
agreement may be explained by the child’s increased
likelihood to share his/her experiences and feelings
with several people he/she can rely on (e.g., ex-
tended family, neighbors, peers, etc.), other than the
parents. However, this finding should not be inter-
preted as a “negative effect”, since it provides the
child alternative ways of coping with the health con-
dition and its psychosocial impairments, and may
ease parents’ responsibilities and caregiving burden.
A recent study in pediatric asthma found that a
greater caregiving burden was associated with in-
creased discrepancies in both directions [25]. By
sharing caregiving responsibilities with the social
support network and reducing the caregiving burden,
the parents may become more likely to “normalize”
the child’s health condition and rate their HrQoL as
superior (nearing the pattern of parent-child discrep-
ancies described for healthy children).
Moreover, greater parental burden resulting from caring
for a child with short stature, including more worries and
negative feelings, were associated with larger absolute dis-
crepancies and with larger discrepancies in the direction
of parents reporting worse condition-specific HrQoL than
the children. White-Koning et al. [29] described a signifi-
cant association between higher levels of parenting stressand parents’ underrating the HrQoL of their children with
cerebral palsy. In addition, in another pediatric asthma
study, the illness-related burdens experienced by parents
were negatively associated with parents’ reports of
pediatric HrQoL [33], which may contribute to child-
parent disagreement in the direction of parents reporting
worse HrQoL than the children. Parents’ perceptions of
caregiving tasks and chronic-disease management routines
as overly demanding and burdensome have also been as-
sociated with negative mother-child interactions [58],
which may limit the exchange of information between
children and parents. Moreover, the caregiving burden is
likely to negatively affect parents’ perceptions of family re-
lationships [59] and thus contribute indirectly to parent-
child disagreement on HrQoL reports.
Some limitations should be acknowledged in the
interpretation of the findings from the present study.
Even if GHD and ISS are rare diseases and ISS is
not routinely treated with GH in Europe, the small
sample size may limit the generalizability of the re-
sults. In addition, the use of data only from the re-
test phase of the European QoLISSY study and the
exclusion of cases with missing clinical data, al-
though random, may skew the data and reduce the
statistical power of the analyses. Second, the non-
probabilistic sampling strategy may have influenced
the levels of agreement because parents who partici-
pated may be more involved in pediatric healthcare
than parents who had refused to participate. In
addition, most parents’ reports were provided by the
mothers (75.9 %). Although this is common in
pediatric research [60], the disproportionate partici-
pation of mothers and fathers limited the ability to
assess the potential role of the parents’ sex in
explaining the extent and direction of parent-child
discrepancies. A third limitation concerns the
methods of data collection. Since the questionnaires
were completed by the parents and the children at
home, a parental influence on children’s answers
cannot be ruled out, even if the parents were specif-
ically instructed to not interfere with their children’s
responses. Despite the possibility of some bias intro-
duced by any exchange of information between par-
ent and child while they were filling in the
questionnaires, we believe that the high levels of
agreement would be better explained by the instru-
ment characteristics (e.g., the relevance of different
domains for this specific clinical group). Forth, the
absence of psychosocial variables assessment at base-
line prevents the examination of the impact of
changes in family and social relationships in the
rates of parent-child agreement. Finally, the low
Cronbach’s alpha coefficient for the Oslo 3-items So-
cial Support Scale must be mentioned.
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Despite the above mentioned limitations, our findings
have important implications for research and clinical
practice. Routine assessment of pediatric HrQoL in
healthcare and research contexts should not only include
self- and parent-reported data as complementary sources
of information, they should also consider the family and
social context. Besides, the possible (dis)agreement be-
tween parents and children should lead not only to the
consideration of which informant is most objective or
valid, but also to questions about what meaning these
differences might have in the context of the parent-child
relationship or the family’s psychosocial status and even-
tually lead to further assessment of these dimensions of
the families’ life. The additional cost of conducting a
more in-depth assessment of HrQoL and its determi-
nants can be offset through a deeper understanding of
how to interpret self- and observer-reported data. Based
on knowledge about determinants of discrepancies in
HrQoL ratings, prospective studies should address dif-
ferences in scores as an option for integrating parent
and patient reports in relation to clinical outcomes.
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